1. Home
  2. AGIO vs ABR Comparison

AGIO vs ABR Comparison

Compare AGIO & ABR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AGIO
  • ABR
  • Stock Information
  • Founded
  • AGIO 2007
  • ABR 2003
  • Country
  • AGIO United States
  • ABR United States
  • Employees
  • AGIO N/A
  • ABR N/A
  • Industry
  • AGIO Biotechnology: Pharmaceutical Preparations
  • ABR Real Estate Investment Trusts
  • Sector
  • AGIO Health Care
  • ABR Real Estate
  • Exchange
  • AGIO Nasdaq
  • ABR Nasdaq
  • Market Cap
  • AGIO 2.4B
  • ABR 2.7B
  • IPO Year
  • AGIO 2013
  • ABR 2004
  • Fundamental
  • Price
  • AGIO $35.42
  • ABR $13.78
  • Analyst Decision
  • AGIO Buy
  • ABR Hold
  • Analyst Count
  • AGIO 7
  • ABR 6
  • Target Price
  • AGIO $56.33
  • ABR $14.25
  • AVG Volume (30 Days)
  • AGIO 1.1M
  • ABR 2.1M
  • Earning Date
  • AGIO 02-13-2025
  • ABR 02-14-2025
  • Dividend Yield
  • AGIO N/A
  • ABR 12.50%
  • EPS Growth
  • AGIO N/A
  • ABR N/A
  • EPS
  • AGIO 11.80
  • ABR 1.35
  • Revenue
  • AGIO $32,871,000.00
  • ABR $650,354,000.00
  • Revenue This Year
  • AGIO $33.38
  • ABR N/A
  • Revenue Next Year
  • AGIO $163.06
  • ABR N/A
  • P/E Ratio
  • AGIO $3.00
  • ABR $10.18
  • Revenue Growth
  • AGIO 36.79
  • ABR N/A
  • 52 Week Low
  • AGIO $20.96
  • ABR $11.92
  • 52 Week High
  • AGIO $62.58
  • ABR $16.35
  • Technical
  • Relative Strength Index (RSI)
  • AGIO 28.75
  • ABR 34.33
  • Support Level
  • AGIO $37.20
  • ABR $13.65
  • Resistance Level
  • AGIO $44.46
  • ABR $14.55
  • Average True Range (ATR)
  • AGIO 4.27
  • ABR 0.34
  • MACD
  • AGIO -2.06
  • ABR -0.05
  • Stochastic Oscillator
  • AGIO 1.06
  • ABR 25.70

About AGIO Agios Pharmaceuticals Inc.

Agios Pharmaceuticals Inc is a biopharmaceutical company with a focus on developing treatments geared towards cancer and rare genetic disorders of metabolism. The company's primary focus is to develop potentially transformative small-molecule medicines. The clinical development plan for Agios' product candidates includes a precision approach with initial study designs that allow for genetically or biomarker-defined patient populations. The company seeks the potential for proof of concept early in clinical development, along with any potential for accelerated approval.

About ABR Arbor Realty Trust

Arbor Realty Trust Inc is a specialized real estate finance company. It invests in a diversified portfolio of structured finance assets in the multifamily and commercial real estate markets, consisting of bridge and mezzanine loans, including junior participating interests in first mortgages, preferred, and direct equity. In addition, it may also directly acquire real property and invest in real estate-related notes and certain mortgage-related securities. The company has two business segments, Structured Business and Agency Business. It generates a majority of its revenue from the Structured Business Segment. The company is externally managed and advised by Arbor Commercial Mortgage, LLC.

Share on Social Networks: